Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 15:43
Journey Medical Debt to Equity Ratio : 0.7945 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.7945 |
| June 30, 2026 | 0.7953 |
| March 31, 2026 | 0.826 |
| December 31, 2025 | 0.7973 |
| September 30, 2025 | 0.9769 |
| June 30, 2025 | 1.313 |
| March 31, 2025 | 1.168 |
| December 31, 2024 | 1.281 |
| September 30, 2024 | 1.928 |
| June 30, 2024 | 2.019 |
| March 31, 2024 | 1.372 |
| December 31, 2023 | 0.8713 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.1802 |
| June 30, 2023 | 2783.80 |
| March 31, 2023 | 3.572 |
| December 31, 2022 | 1.568 |
| September 30, 2022 | 0.9703 |
| June 30, 2022 | 0.6115 |
| March 31, 2022 | 0.5101 |
| December 31, 2021 | 0.2152 |
| September 30, 2021 | -3.514 |
| June 30, 2021 | -29.71 |
| March 31, 2021 | |
| December 31, 2020 | 1.248 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Talphera, Inc. | 0.6067 |
| Fortress Biotech, Inc. | 0.2434 |
| Relmada Therapeutics, Inc. | 0.00 |
| Turn Therapeutics, Inc. | 1.095 |
| ANI Pharmaceuticals, Inc. | 0.9531 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 103.85M |
| Total Liabilities (Quarterly) | 71.60M |
| Shareholders Equity (Quarterly) | 32.25M |
| Current Ratio | 1.481 |
| Net Debt Paydown Yield | -0.04% |